Search This Blog

Labels

BREAKING NEWS: G 3/19 - Plants and animals exclusively obtained by essentially biological processes are not patentable, but no retroactive effect

Today, the EPO issued a Press Communiqué concerning opinion G 3/19 of the Enlarged Board of Appeal. (link)

The Press Communiqué is cited in full below (with emphasis added).

The full decision can be found here (G 3/19). Further references are given at the end of the Press Communiqué.

The headnote of the decision reads:

Taking into account developments after decisions G 2/12 and G 2/13 of the Enlarged Board of Appeal, the exception to patentability of essentially biological processes for the production of plants or animals in Article 53(b) EPC has a negative effect on the allowability of product claims and product-by-process claims directed to plants, plant material or animals, if the claimed product is exclusively obtained by means of an essentially biological process or if the claimed process features define an essentially biological process. This negative effect does not apply to European patents granted before 1 July 2017 and European patent applications which were filed before that date and are still pending.

----
[start of citation of Press Communiqué]

Press Communiqué of 14 May 2020 concerning opinion G 3/19 of the Enlarged Board of Appeal


The Enlarged Board of Appeal of the European Patent Office issued opinion G 3/19 (Pepper) today and concluded that plants and animals exclusively obtained by essentially biological processes are not patentable.
The Enlarged Board of Appeal of the European Patent Office adopted a dynamic interpretation of the exception to patentability under Article 53(b) of the European Patent Convention (EPC) and held that the non-patentability of essentially biological processes for the production of plants or animals also extends to plant or animal products that are exclusively obtained by means of an essentially biological process.

Background

The Enlarged Board of Appeal is the highest judicial authority under the EPC, which provides for an autonomous legal system that is separate from the European Union. The Enlarged Board's main task is to ensure the uniform application of the EPC.
Under Article 53(b) EPC, European patents shall not be granted in respect of plant or animal varieties or essentially biological processes for the production of plants or animals. Rule 28(2) EPC provides that under Article 53(b) EPC, European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process. Rule 28(2) EPC was introduced by decision of the Administrative Council of the European Patent Organisation and came into force on 1 July 2017.
In 2015, the Enlarged Board had concluded in its decisions G 2/12 and G 2/13 within the then applicable legal framework, i.e. before the introduction of Rule 28(2) EPC, that the non‑patentability of essentially biological processes for the production of plants or animals under Article 53(b) EPC did not extend to products that are exclusively obtained by means of an essentially biological process.
In 2018, a Technical Board of Appeal held in decision T 1063/18 that new Rule 28(2) EPC had no impact on the interpretation of Article 53(b) EPC, and followed the Enlarged Board's earlier decisions G 2/12 and G 2/13.
In 2019, the President of the European Patent Office referred a point of law to the Enlarged Board of Appeal under Article 112(1)(b) EPC concerning the interpretation of Article 53(b) EPC in view of legal and other developments occurring after decisions G 2/12 and G 2/13, and in particular in view of new Rule 28(2) EPC.

Key considerations

In its opinion issued today, the Enlarged Board of Appeal held the referral by the President of the European Patent Office to be admissible within the terms of a re‑phrased question. On the merits of the referral, the Enlarged Board endorsed its earlier findings on the scope of Article 53(b) EPC, which were based on the classical (i.e. the grammatical, systematic, teleological and historical) methods of interpretation. However, the Enlarged Board found that a particular interpretation which has been given to a legal provision can never be taken as carved in stone, because the meaning of the provision may change or evolve over time. This meant that decisions G 2/12 and G 2/13 did not settle the meaning of Article 53(b) EPC once and for all.
Taking account of the Administrative Council's decision to introduce Rule 28(2) EPC, the preparatory work on this provision and the circumstances of its adoption, as well as legislative developments in the EPC contracting states, the Enlarged Board concluded that new Rule 28(2) EPC allowed and indeed called for a dynamic interpretation of Article 53(b) EPC.
In adopting this dynamic interpretation, the Enlarged Board abandoned its earlier interpretation of Article 53(b) EPC in decisions G 2/12 and G 2/13. It held that, after the introduction of new Rule 28(2) EPC, Article 53(b) EPC was to be interpreted to exclude from patentability plants, plant material or animals, if the claimed product is exclusively obtained by means of an essentially biological process or if the claimed process features define an essentially biological process.
In order to ensure legal certainty and to protect the legitimate interests of patent proprietors and applicants, the Enlarged Board ruled that the new interpretation of Article 53(b) EPC given in G 3/19 had no retroactive effect on European patents containing such claims which were granted before 1 July 2017, or on pending European patent applications seeking protection for such claims which were filed before that date.

Contact

Nikolaus Obrovski
Spokesperson of the Boards of Appeal of the European Patent Office
BOA-PRESS@epo.org
This press release is a non-binding document for media use.

Further information

06.07.1998
EU Directive 98/44/EC of the European Parliament and of the Council on the legal protection of biotechnological inventions;
16.06.1999
Decision CA/D 10/99 of the Administrative Council, insertion of new Chapter VI "Biotechnological inventions" in Implementing Regulations to the EPC;
09.12.2010
G 2/07 (Broccoli I), Decision of the Enlarged Board of Appeal;
G 1/08 (Tomatoes I), Decision of the Enlarged Board of Appeal;
25.03. 2015
G 2/12 (Tomatoes II), Decision of the Enlarged Board of Appeal;
G 2/13 (Broccoli II), Decision of the Enlarged Board of Appeal;
01.07.2017
Rule 28(2) EPC (entry into force), see Decision CA/D 6/17 of the Administrative Council;
05.12.2018
T 1063/18, Decision of Technical Board of Appeal 3.3.04;
decision text (not published in OJ EPO)
05.04.2019
Referral of a point of law by the President of the EPO;
14.05.2020
G 3/19 (Pepper), Opinion of the Enlarged Board of Appeal;
opinion text (not yet published in OJ EPO)
Amicus curiae briefs
[end of citation of Press Communiqué]
----

G 3/19 - Patentability of plants exclusively obtained by essentially biological processes: the referral


The full text of the referral by the President to the Enlarged Board of Appeal relating to the patentability of plants exclusively obtained by essentially biological processes is available online. Also see our earlier posts (w.r.t annoucemcentearlier annoucement T 1063/18 and first news message)). The accompanying letter is dated 4.04.2019 and was received in the BoA Office on 08.04.2019.


Under Article 112(1)(b) EPC the President of the European Patent Office refers the following points of law to the Enlarged Board of Appeal:

1. Having regard to Article 164(2) EPC, can the meaning and scope of Article 53 EPC be clarified in the Implementing Regulations to the EPC without this clarification being a priori limited by the interpretation of said Article given in an earlier decision of the Boards of Appeal or the Enlarged Board of Appeal?

2. If the answer to question 1 is yes, is the exclusion from patentability of plants and animals exclusively obtained by means of an essentially biological process pursuant
to Rule 28(2) EPC in conformity with Article 53(b) EPC which neither explicitly excludes nor explicitly allows said subject-matter?

T 1063/18 - The full decision: why Rule 28(2) is in conflict with Art.53(b) EPC and why no referral was necessary


On 7 December, the Board of Appeal posted a communication on their website wherein the decision in case T 1063/18 on the patentability of plants was summarized (see here). Yesterday, the complete written decision was issued and became available in the register. In the Decision, the Board does not only motivate in detail why Rule 28(2) EPC as it was amended is in conflict with Art. 53(b) EPC as interpreted by the Enlarged Board in G 2/12 and G 2/13, as well as why the Adm Council was not competent to adopt this Rule, as well as why no further referral was needed - the Board also explained why they consider the opinion of the Enlarged Board to be unchanged also after the Commission Notice after the amendment to Rule 28(2) EPC. Not all arguments submitted by the parties and third parties were addressed in view of the intermediate conclusions taken - so, unfortunately, whether there is a difference as to what the scope of the exclusion of "essentially biologial processes" or not, was not discussed by the Boards (one submission argued that the Commission uses a narrow exclusion (strictly 100% biological, without any techncal step) whereas the Enlarged Board uses a broad exclusion (crossing whole genomes, irrespective of whether further technical steps are also excluded): if Rule 28(2) EPC would have been maintained, that could have meant that it excluded more than was intended.
This will probably not be the last legal development on patentability of "plants exclusively obtained by means of an essentially biological process" via Art. 53(b) EPC or otherwise... 


Hot News: T 1063/18 - Rule 28(2) EPC in conflict with Art.53(b) as interpreted by the EBoA in G 2/12 and G 2/13.


Hot News: Communication from the BoAs (link):

Decision in case T 1063/18 on the patentability of plants

7 December 2018

Case T 1063/18 concerns the appeal by the applicant against the decision of the examining division to refuse European patent application no. 12 756 468.0 (publication no. EP 2 753 168) for the sole reason that the claimed subject-matter falls within the exception to patentability according to Article 53(b) and Rule 28(2) EPC (here: plants exclusively obtained by means of an essentially biological process).

At the oral proceedings, which took place on 5 December 2018, Technical Board of Appeal  3304, in an enlarged composition consisting of three technically and two legally qualified members, held that Rule 28(2) EPC (see OJ 2017, A56) is in conflict with Article 53(b) EPC as interpreted by the Enlarged Board of Appeal in decisions G 2/12 and G 2/13. The Board referred to Article 164(2) EPC, according to which the provisions of the Convention prevail in case of conflict with the Implementing Regulations, and decided to set the decision under appeal aside and to remit the case to the examining division for further prosecution.

The written decision containing the board's full reasons is expected to be issued early next year.

We will post another blog as soon as the written decision is available The file wrapper can be found here. Photo "Farmer's Market Summer Colors" by Luxbao obtained via Flickr under Public Domain Mark 1.0

------------------------------
Update 19-12-2018: Minutes from Oral proceedings before the Board available

The minutes from the oral Proceedings of 5 December 2018 are available in the EP Register (here) and are cited in full below (emphasize aded by the blog editor).

Appeal number T1063/18-3.3.04

Application No.: 12756468.0
Applicant: Syngenta Participations AG


Minutes of the oral proceedings
of 5 December 2018

Composition of the Board:

Chair: G. Alt
Members: R. Morawetz
                 P. de Heij
                 A. Chakravarty
                 L. Bühler

Start of oral proceedings: 09:30 hours
End of oral proceedings:  13:00 hours

 Present on behalf of the appellant:

Mr M. A. Kock, authorised by an authorisation dated 19 October 2018, and Mr N. Amelot, professional representatives, both identified by EPO-identity card.

The chair declared the oral proceedings open. She noted that the board had been enlarged pursuant to Article 21(3)(b) EPC and Article 9 RPBA. She then summarised the relevant facts as they appeared from the file. The appellant confirmed that they had received all third parties observations on file.

The chair stated that the board had taken note of the third parties observations. The chair also stated that the board intended to decide whether the decision to refuse the application was correct.

The chair ascertained the appellant ’s opening requests which the board understood to be as follows.

The appellant requested:

- as the main request: That the decision under appeal be set aside and, should the board remain of the opinion that the grounds raised in the communication of the board prevented the application from being granted, the case be remitted to the examining division for further prosecution on the basis of the set of claims filed on 7 August 2015;

- as auxiliary request 1: Should the board not be in a position to take a decision on the validity and/or scope of Rule 28(2) EPC according to the main request or see points of law of fundamental importance, questions be referred to the Enlarged Board of Appeal as suggested in the statement of grounds of appeal dated 5 April 2018, including a question to clarify the apparent contradiction between the definitions of essentially biological processes under G 2/07 and under Rule 27(c) EPC and the Biotechnology Directive 98/44, as further construed by the Commission Notice;

- as auxiliary request 2: Should the board be minded to dismiss the appeal without deciding on the appellant's main request to set aside the decision of the examining division, the following question be submitted to the Enlarged Board of Appeal: "Is a Board of Appeal entitled to reject an appeal on grounds not related to the appeal without first deciding on the Appellant's Main Request to set aside the decision of the Examining Division?";

- as auxiliary request 3: Should the board intend to reject the request to remit the case to the examining division for further prosecution on the basis of the set of claims filed on 7 August 2015, a patent be granted on the basis of an amended set of claims filed as auxiliary request 4 with the letter dated 26 October 2018.

The chair summarised the appellant’s different lines of argument presented in writing. She noted that one of these lines was that Rule 28(2) EPC was in conflict with Article 53(b) EPC, as interpreted by the Enlarged Board of Appeal in decisions G 2/12 and G 2 /13, and that therefore Article 164(2) EPC applied. She invited the appellant to first present comments on this line of argument.

The appellant presented their arguments on the matter and stated that they agreed with the observations of the third party Konig, which the board should take into consideration, and had nothing to add to the comments provided by Konig on the observations of the third party ESA (European Seed Association). [Note: both third parties made multiple submissions - see EP Register]

After deliberation, the chair announced that the board was of the opinion that Rule 28(2) EPC was in conflict with Article 53(b) EPC, as interpreted by the Enlarged Board of Appeal in decisions G 2/12 and G 2/13, and that in accordance with Article 164(2) EPC the provisions of the Convention prevailed.

Next, the appellant presented their arguments in support of the request for remittal to the examining division. These were, inter alia, that the objections of lack of inventive step and lack of clarity had been raised by the board and that they had the right to have these objections considered by two instances.

After another break for deliberation by the board, the chair stated that the board would not order the remittal of the case at the present stage of the oral proceedings, but would reconsider the request after the appellant had been heard on the issue of inventive step of the subject-matter of claim 1 of the main request. There was no loss of instance for this issue because the examining division had provided an opinion on inventive step.

As regards document D1 and the San Luis Ancho pepper disclosed therein, the appellant submitted that it was not known whether the features in claim 1 defining the extreme dark green colour of the fruit at immature harvestable state, i.e. the chlorophyll A and chlorophyll B, lutein and violaxanthin  content, were inherent features of the San Luis Ancho pepper. The dark green colour of the pepper as not necessarily linked to these features. An analysis of the chlorophyll and carotenoid content of the San Luis Ancho pepper could provide the relevant information, however, the appellant's experts had not had sufficient time to carry out such an analysis.

The proceedings were again interrupted for deliberation of the board. After resumption, the chair announced that the board had reconsidered the request for remittal and had decided to remit the case to the examining division for further prosecution. This would allow the appellant to carry out an  analysis of the San Luis Ancho pepper to support their arguments on inventive step.

The chair asked the appellant to state their final requests. These were the same as their opening requests.

The chair asked the appellant if they had any further comments or observations. They had none.

The chair then closed the debate and announced the following decision of the board:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division for further prosecution on the basis of the set of claims of the main request, as filed on 7 August 2015.

The chair then closed the oral proceedings.

The Minute Writer: P. de Heij
The Chair: G. Alt









No longer a European patent for plants or animals exclusively obtained by an essentially biological process


As we discussed in our blog of 19 December 2016, there has been a long debate about patentability of plants/animals under the EPC. 
The final (?) chapter may now be closed: the Administrative Council took a decision to amend the relevant Regulations in order to exclude from patentability plants and animals exclusively obtained by an essentially biological breeding process.  This ends the option allowed by the Enlarged Board in G2/12 and G 2/13. The new rule enters in force almost immediately on 1 July 2017.

The key change to the rules is to introduce a new paragraph to R.28 (the current content being moved to R.28(1)):

R.28(2) Under Article 53(b), European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process.

To make sure that R.27(b) cannot be used as an escape, this rule has been made subject to R.28(2):
R.27 Biotechnological invention shall also be patentable if they concern:
(a) ...
(b) without prejudice to Rule 28, paragraph 2, plants or animals if the technical feasibility of the invention is not confined to a particular plant or animal variety;
(c) ...

The full text of the press release of the EPO can be found here and is reproduced below.

Broccoli and Tomatoes followup: staying of proceedings due to the Commission Notice on certain articles of Directive 98/44/EC

 

In G 2/12 and G 2/13 (decision, blog), the Enlarged Board of Appeal concluded that the exclusion of essentially biological processes for the production of plants in Article 53(b) EPC does not have a negative effect on the allowability of a product claim directed to plants or plant material such as plant parts. The decision led to a successful maintenance in amended form in the Broccoli case (decision, blog, register) as well as in the Tomatoes case (decision, blog, register).
The decision also led to a discussion in the European Commission. On 3 November 2016 ,the European Commission adopted a notice on certain articles of Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions ("the (Biotech Directive"/ "The Directive"). With regard to the patentability of plants and animals obtained by means of essentially biological processes, the Commission takes the view that in accordance with the EU legislator's intention such plants and animals are not patentable under the Directive.
The effect of the Commission Notice for the EPO's examination practice including any necessary follow-up measures is currently under discussion with the representatives of the member states of the European Patent Organisation.
The President of the EPO has decided that, in view of the potential impact of the Commission Notice, all proceedings before EPO examining and opposition divisions in which the decision depends entirely on the patentability of a plant or animal obtained by an essentially biological process will be stayed ex officio. The details are given in the Notice that is reproduced below, together with parts of the Commission Notice.


G 2/12 and G 2/13 - Fruit and veggies


On 25 March 2015 the Enlarged Board of Appeal published the consolidated decisions G 2/12 (Tomatoes II) and G 2/13 (Broccoli II). Whereas the EBoA decided in G 1/08 (Tomatoes I) and G 2/07 (Broccoli I) that the processes as claimed in the respective patents at stake were not allowable under Article 53(b) EPC (that indicates that plants and plant varieties or essentially biological processes for the production of plants are unpatentable), the EBoA now came to the (not unexpected) conclusion that this article in the EPC does not prevent patenting the plant products (e.g. fruit and edible parts of the plant) that may be obtained by such processes. Interestingly, all parties involved (patent proprietors, opponents as well as the President of the EPO) agreed with this notion, before the EBoA confirmed it.
The EBoA once again stresses the difference between a product claim, a process claim and a product-by-process claim, the latter being a product claim that should be addressed for patentability separate from the process that is used to produce it.

The EBoA concluded earlier in G 2/07 and G 1/08 that the legislator's intention (Article 53(b) EPC) had been to exclude from patentability those plant breeding processes which were the conventional methods of plant-variety breeding at the time. 
Article 53(b) EPC is about an essentially biological process that cannot be patented. But if one claims a product (not a plant or a plant variety) that may be obtained by such excluded process, such product may very well be patentable and is explicitly not excluded from patentability under Article 53(b) EPC, solely because it was obtained by the unpatentable process.  

Notably, and the EBoA admits this, in some EPC contracting states, including Germany and the Netherlands, the patent law deviates from the EPC by explicitly excluding patentability of products obtained by essentially biological processes (e.g. see Art. 3(1)(d) ROW 1995). The EBoA indicates that such is not the case in the EPC.

Ergo: not all is lost for parties pursuing European patent protection for commercial plant products (like fruit) when the process leading to such products falls under the exclusion of Article 53(b) EPC, at least not in all contracting states of the EPC.


T 1729/06 - Production of seedless water melons: plants or fruits?



This is an appeal against a decision from the examining division, which refused the present application for the sole reason that the claimed subject-matter was an essentially biological process for the production of plants for which pursuant to Article 53(b) EPC no patents shall be granted. The applicant contested the objection, arguing that the claims were, rather than to a method for the production of plants per se, directed to a process for the industrial production of seedless watermelon fruits for human consumption. 


Reasons for the Decision
[...]
Main request - Article 53(b) EPC
3. The examining division refused the present application for the sole reason that the claimed subject-matter (of both the main request and auxiliary request) was an essentially biological process for the production of plants for which pursuant to Article 53(b) EPC no patents shall be granted.
Context of the invention described in the application
4. The present invention is in the field of the production of watermelon fruit, in particular of seedless watermelons (see page 1, lines 5 to 8 of the application as filed).
5. From a botanical point of view the board notes that the watermelon is a monoecious plant and thus has separate male and female flowers on the same plant. The board notes furthermore that seedless watermelons have been produced and marketed for human consumption since the early 1950s (see e.g. WO00/70933, page 1, lines 21 to 25, referred to on page 2, line 11 of the application as filed).
6. Watermelon plants setting seedless fruits (see e.g. "Development of Seedless Watermelons", page 9, line 27 to page 11, line 13 of the application as filed) are produced by crossing a tetraploid (4n=44) inbred line as the female plant with a diploid (2n=22) inbred line as the male parent (note by the board: the reciprocal cross does not produce seeds). The resulting triploid (3n=33) seeds can be germinated and grown into a triploid watermelon plant bearing triploid male and female flowers. Characteristically for triploid organisms, however, these triploid plants are female and male sterile, i.e. they produce neither female nor male gametes. The reason for this sterility is that triploid plant cells have three sets of chromosomes and one of these sets will not have a matching (homologous) set to pair up with during synapsis of prophase 1 of meiosis. This failure of synapsis results in an improper meiosis and therefore in gametes that are not viable. Accordingly, because the triploid watermelon plant is female sterile, no fertilisation (i.e. union of female and male gametes) inside the female flower can take place and embryo-bearing seeds are not typically formed on triploid watermelon plants.
7. Triploid watermelon plants are also male sterile and hence self-pollination does not take place. However, in order for triploid watermelon plants to develop fruits (note by the board: i.e. such fruits being seedless watermelons which consist entirely of tissues of the triploid plant), pollination of the sterile female flowers is required (note by the board: for fruit development fertilisation is however not required). It is thus necessary to plant (diploid) watermelon polleniser plants in the watermelon production field to provide the necessary pollen to pollinate the triploid female flowers and thereby stimulate fruit development.
8. The present application is mainly concerned with the development and the use of particularly advantageous diploid enhanced polleniser plant lines, e.g. NO1F3203B (see "Development of Enhanced Pollenizer Diploid Watermelon", page 11, line 15 to page 15, line 29) and their use in the production of triploid watermelon fruits.
The claimed invention
9. It is in the context of the invention as described above that the claimed subject-matter (see section II, above) is to be assessed:
Independent claim 1 is directed to the use of a particular diploid watermelon plant as polleniser for triploid watermelon plants, in a process of producing triploid seedless water melon fruit. [Note: emphasis present in the decision - see the pdf version].
Independent claim 5 is directed to a method for producing triploid seedless water melon fruit which comprises the steps of planting triploid watermelon plants and a particular diploid watermelon plant and allowing the pollination of the triploid plants by the diploid plants to obtain the triploid seedless watermelon fruit.
Independent claims 6 and 7 are directed to methods for increasing the yield of triploid, seedless watermelon plants comprising the steps of planting particular diploid polleniser watermelon plants and allowing them to pollinate triploid watermelon plants to produce triploid, seedless watermelon fruit followed by the harvesting of this fruit. Claim 7 comprises the additional step of eliminating the unharvested fruits of the diploid watermelon plants.
10. The subject-matter of the claims is therefore directed to those steps in the production process of seedless watermelons which involve the (planting and) growing of the triploid and diploid watermelon plants, the pollination of the triploid female flowers by the diploid pollen and the development of the seedless watermelon fruit on the triploid plant.
The exclusion from patentability of "essentially biological processes for the production of plants" in the EPC
11. Article 53(b) EPC provides that: "European patents shall not be granted in respect of (b) ... essentially biological processes for the production of plants ...; this provision shall not apply to microbiological processes ...".
12. It has not been argued by the appellant that the claimed use and methods are equivalent to microbiological processes in the sense of the Article 53(b) EPC. The board also considers that these uses and methods are not microbiological processes within the meaning of Article 53(b) EPC. It therefore needs to be assessed by the board, whether or not the claimed use and methods constitute "essentially biological processes for the production of plants" within the meaning of Article 53(b) EPC.
Processes for the production of plants considered excluded from patentability by virtue of Article 53(b) EPC by the Enlarged Board of Appeal
13. The meaning and the scope of the process exclusion in Article 53(b) EPC were considered by the Enlarged Board of Appeal in decision G 1/98 (OJ EPO 2000, 111) and, recently, in great detail in the consolidated decisions G 2/07 and G 1/08 (OJ EPO 2012, 130 and 206).
14. In its decision G 1/98, supra, the question raised by this referring board (in a different composition) in its referring decision T 1054/96 (OJ EPO 1998, 511) of how to decide whether a process can be defined as an "essentially biological process" was, however, left unanswered by the Enlarged Board of Appeal (see decision G 1/98, supra, point 6 of the reasons). Decision G 1/98, supra, is therefore not of direct assistance in this matter.
15. The relevant questions raised by this board (in a different composition) in its referring decisions T 83/05 (OJ EPO 2007, 644) and T 1242/06 (OJ EPO 2008, 523) were, however, answered by the Enlarged Board of Appeal in its decisions G 2/07, supra, and G 1/08, supra.
16. In summary, after an analysis of the object and purpose of the process exclusion of Article 53(b) EPC, the Enlarged Board of Appeal came in its decisions G 2/07, supra, and G 1/08, supra, to the conclusion that (emphasis added by the board) "[a] non-microbiological process for the production of plants which contains or consists of the steps of sexually crossing the whole genome of plants and of subsequently selecting plants [was] in principle excluded from patentability as being "essentially biological" within the meaning of Article 53(b) EPC" (see decision G 2/07, supra, Headnote, answer 1). These "processes were characterised by the fact that the traits of the plants resulting from the crossing were determined by the underlying natural phenomenon of meiosis. This phenomenon determined the genetic make-up of the plants produced, and the breeding result was achieved by the breeder's selection of plants having the desired traits" (see decision G 2/07, supra, point 6.4.2.3 of the reasons; the full paragraph on page 199). In the context of these, in principle, excluded processes, the Enlarged Board of Appeal added however the qualifications that "[s]uch a process does not escape the exclusion of Article 53(b) EPC merely because it contains, as a further step or as part of any of the steps of crossing and selection, a step of a technical nature which serves to enable or assist the performance of the steps of sexually crossing the whole genomes of plants or of subsequently selecting plants" (see decision G 2/07, supra, Headnote, answer 2) and that "[i]f, however, such a process contains within the steps of sexually crossing and selecting an additional step of a technical nature, which step by itself introduces a trait into the genome or modifies a trait in the genome of the plant produced, so that the introduction or modification of that trait is not the result of the mixing of the genes of the plants chosen for sexual crossing, then the process is not excluded from patentability under Article 53(b) EPC" (see decision G 2/07, supra, Headnote, answer 3).
17. In the case at hand, the claimed use and methods all concern the step of the pollination of triploid watermelon plants by pollen of a particular diploid polleniser watermelon plant and result in the development of triploid seedless watermelon fruit on the triploid watermelon plants (see point 10, above). They aim therefore in essence at the production of triploid seedless watermelon fruit on existing triploid watermelon plants and not at the creation of any genetic make-up of any plant produced as the result of meiosis. Indeed, as explained in points 5 and 6, above, the use and methods do not involve successful meiosis in the triploid plant flowers. Rather, they merely concern the pollination of the sterile female flowers of the triploid watermelon plant with pollen of the diploid polliniser plant. They do not concern sexually crossing two whole genomes of plants (implying meiosis and fertilisation) and the subsequent selection of plants.
18. The board is therefore satisfied that the use and methods as subject-matter of the claims are not such methods which the Enlarged Board of Appeal in its decisions G 2/07, supra, and G 1/08, supra, considered to fall under the exclusion of "essentially biological processes for the production of plants" pursuant to Article 53(b) EPC.
Further considerations by this board on the process exclusion in Article 53(b) EPC in the light of observations by the Enlarged Board of Appeal in decisions G 2/07 and G 1/08
19. Although, on the one hand, the Enlarged Board of Appeal, in its decisions G 2/07, supra, and G 1/08, supra, has given extensive guidance which processes for the production of plants are "in principle" excluded from patentability by virtue of the process exclusion in Article 53(b) EPC (see point 16, above), the board notes that, on the other hand, the Enlarged Board of Appeal has not, in these decisions, given a comprehensive and exhaustive definition of the subject-matter to which the process exclusion in Article 53(b) EPC applies in relation to plant inventions.
20. Indeed, both cases underlying the referring decisions in the cases G 2/07, supra, and G 1/08, supra, were concerned with processes in which the desired trait of the (resulting) plant was achieved by crossing and selection, i.e. they were breeding methods (for the production of plants). This fact was recognised and acknowledged by the Enlarged Board of Appeal when it stated that "[b]oth cases as they underlie the referring decisions are concerned with processes in which the desired trait of the plant is achieved by crossing and selection, i.e. they are breeding methods" (see decision G 2/07, supra, point 6.1.2 of the reasons). The Enlarged Board of Appeal considered subsequently, that "[h]ence, any potential difference in the meaning of the English wording of Article 53(b) EPC "method for the production" of plants as compared with its German and French texts ("Züchtungsverfahren", "procédé d'obtention") [did] not appear relevant for the referred issues" (see point 6.1.2 of the reasons).
21. A further indication that the Enlarged Board of Appeal in its decisions in fact did not give an exhaustive definition of the subject-matter to which the process exclusion in Article 53(b) EPC is applicable in relation to plant inventions can be found in point 6.4.2.3 (on page 199) of the reasons for decision G 2/07, supra. Here the Enlarged Board of Appeal stated that "[i]t must be concluded that the legislator's intention was to exclude from patentability the kind of plant breeding processes which were the conventional methods for the breeding of plant varieties of that time. These conventional methods included in particular those (relevant for the present referrals) based on the sexual crossing of plants (i.e. of their whole genomes) deemed suitable for the purpose pursued and on the subsequent selection of the plants having the desired trait(s)" (emphasis added by the board).
22. The board therefore considers that, notwithstanding the conclusion in point 18, above, it still needs to establish whether or not the claimed uses and methods of the present case are excluded from patentability by virtue of the process exclusion in Article 53(b) EPC for other reasons.
Biotechnological inventions are patentable under the EPC
23. Rule 26(2) EPC states that "biotechnological inventions are inventions which concern a product consisting of or containing biological material or a process by means of which biological material is produced, processed or used", whereby "biological material" is defined in Rule 26(3) EPC as any material containing genetic information and capable of reproducing itself or being reproduced in a biological system. Undoubtedly the presently claimed use and methods therefore concern "biotechnological inventions" and are therefore, in principle, patentable (Article 52(1) and Rule 27 EPC).
24. In this context, the Enlarged Board of Appeal, in its decisions G 2/07, supra, and G 1/08, supra, established (see decision G 2/07, supra, point 6.4.2 of the reasons) that "biological forces and phenomena, to the extent that they are controllable, are considered to pertain to the area of technologies in which patentable inventions are possible. [...] For biotechnological inventions this is now explicitly enshrined in the EPC and in the Biotech Directive" (see point 23, above and decision G 2/07, supra, page 194, two middle paragraphs; emphasis added by the board). The Enlarged Board stated that "plants and their parts are a material substrate which can be processed by man to achieve a desired result by using natural forces" (see decision G 2/07, supra, page 194, third paragraph).
25. Hence, the board finds that the fruit resulting from the presently claimed uses and methods is "biological material" pursuant to Rule 26(2) EPC. Accordingly, the presently claimed subject-matter, is not explicitly and a priori excluded from being a patentable invention under the EPC.
The object and purpose of Article 53(b) EPC
26. As indicated in point 16, above, in its decisions G 2/07, supra, and G 1/08, supra, the Enlarged Board of Appeal, has extensively analysed the object and purpose of the process exclusion in Article 53(b) EPC as derivable from the legislative history of the relevant provisions in the Strasbourg Patent Convention (SPC) and the EPC 1973 (see decision G 2/07, supra, points 6.4.2.2 and 6.4.2.3 of the reasons).
27. The Enlarged Board of Appeal established that earlier versions of the exclusion now found in Article 53(b) EPC were drafted against the background of the drafting of the UPOV convention (note by the board: concluded in 1961) and the so-called ban on dual protection contained therein.
27.1 The first Preliminary Draft Convention of the EC Working Group of 14 March 1961 contained an Article 12(2) providing an exclusion from patentability for "inventions relating to the production of or a process for producing a new plant variety or a new animal species", whereby this provision was not to apply to processes of a technical nature. It was explained in the comments on the Draft Convention that a process of a technical nature applicable to plants, e.g. processes for producing new plants by irradiation of the plant themselves or the seeds with isotopes, would still have to be granted (see decision G 2/07, supra, point 6.4.2.2, paragraph bridging pages 195 and 196, emphasis added by the board).
27.2 The historical documentation on the drafting of the SPC showed that an originally drafted (optional) exclusion from patentability of "purely biological, horticultural or agricultural (agronomic) processes" (note by the board: not limited to processes for the production of plants and also encompassing e.g. growing of plants) was later removed in the legislative process for being unjustified, as the exclusion of "horticultural or agricultural (agronomic) processes" was considered to exclude a whole "class" of inventions from patentability. Subsequently, the exclusion of "purely biological processes" was re-drafted to the final wording of the exclusion in Article 6 of the SPC which was later taken over, expressis verbis, in the EPC 1973 as Article 53(b) EPC (see decision G 2/07, supra, point 6.4.2.2, page 196, second paragraph to page 197, second paragraph of the reasons). The Enlarged Board of Appeal noted that, according to the explanations given for the final re-drafting, the notion "essentially biological processes for the production of plants and animals" should include those processes which may produce known varieties as well as those which may produce new ones, e.g. selection or hybridisation of known varieties. The new wording "essentially" biological (as opposed to "purely" biological) made it evident that the provision should be extended to cover processes which were fundamentally of this type even if technical devices were involved, e.g. use of a grafting instrument or of a special greenhouse for growing of a plant (see decision G 2/07, supra, point 6.4.2.2, paragraph bridging pages 196 and 197 of the reasons).
28. The board notes in this context that seedless watermelons have been produced and marketed since the early 1950s (see point 5, above). The board accordingly sees no indications in the analysis of the Enlarged Board of Appeal of the object and purpose of Article 53(b) EPC that the legislator(s) intended to cover with the process exclusion such agricultural (agronomic) processes as now claimed in the present application. The board itself has also not been able to identify any such indications in the historical documentation.
More recent legislative developments concerning Article 53(b) EPC
29. The history of more recent legislative developments concerning Article 53(b) EPC have also been analysed in the decisions G 2/07, supra, and G 1/08, supra, of the Enlarged Board of Appeal.
30. Rule 26(5) EPC was introduced in the EPC as Rule 23b(5) EPC 1973 and remained untouched in the revision of the Implementing Regulations to the EPC 2000. Rule 26(5) EPC states that "A process for the production of plants or animals is essentially biological if it consists entirely of natural phenomena such as crossing or selection".
31. The Enlarged Board of Appeal in its decisions judged that Rule 26(5) EPC, because of its ambiguous, if not contradictory, wording, did not give any useful guidance on how to interpret the term "essentially biological process for the production of plants" in Article 53(b) EPC. The board considers, nevertheless, that the Enlarged Board of Appeal's analysis of the legislative history of Rule 26(5) EPC (see decision G 2/07, supra, the whole point 4 of the reasons) contains no indications that the legislator intended to exclude from patentability such use and methods as now claimed in the present application.
Conclusion
32. The board concludes therefore that the legislator drafting Article 53(b) EPC did not have the intention to exclude from patentability a whole class of inventions, i.e. horticultural or agricultural (agronomic) processes, under which the now claimed use and methods undoubtedly fall. Furthermore, the board concludes that the EPC 1973 legislator (and hence the EPC 2000 legislator) only wished to exclude from patentability, in the context of the process aspect of the exclusion in relation to plant inventions, the - then conventional - processes applied by plant breeders in connection with new plant varieties for which a special property right was available under the UPOV Convention and processes which were fundamentally of this type.
33. Accordingly, in view of all the above considerations the board concludes that the use and methods as claimed in the present application are not such as the Enlarged Board of Appeal in its decisions G 2/07, supra, and G 1/08, supra, considered as being excluded from patentability. This is in view of the fact that the use and methods as claimed neither explicitly nor implicitly involve breeding (mixing of whole genomes) and that the use and methods as claimed are rather agricultural, with there being no intention by the legislator to exclude from patentability this "class" of inventions. The board found no indications in the legislative history of Article 53(b) EPC that the now claimed use and methods were intended to be covered by the article. The board therefore considers that, rather than being excluded from patentability by virtue of Article 53(b) EPC, the claimed uses and methods constitute a "technical process" for which the EPC foresees patentability pursuant to Rule 27(c) EPC.
34. The board therefore allows the appeal.
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance for further prosecution on the basis of claims 1 to 8 of the main request filed under cover of a letter dated 7 April 2006.


This decision has European Case Law Identifier: ECLI:EP:BA:2014:T172906.20140917. The whole decision can be found here (pdf). The file wrapper can be found here. Photo "water melon" by Steve Johnson obtained via Flickr.